These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides. Motoyama AB; Hynes NE; Lane HA Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Zhang L; Lau YK; Xia W; Hortobagyi GN; Hung MC Clin Cancer Res; 1999 Feb; 5(2):343-53. PubMed ID: 10037184 [TBL] [Abstract][Full Text] [Related]
7. Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors. Emanuel SL; Hughes TV; Adams M; Rugg CA; Fuentes-Pesquera A; Connolly PJ; Pandey N; Moreno-Mazza S; Butler J; Borowski V; Middleton SA; Gruninger RH; Story JR; Napier C; Hollister B; Greenberger LM Mol Pharmacol; 2008 Feb; 73(2):338-48. PubMed ID: 17975007 [TBL] [Abstract][Full Text] [Related]
8. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice. Sakai Y; Morrison BJ; Burke JD; Park JM; Terabe M; Janik JE; Forni G; Berzofsky JA; Morris JC Cancer Res; 2004 Nov; 64(21):8022-8. PubMed ID: 15520211 [TBL] [Abstract][Full Text] [Related]
9. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [TBL] [Abstract][Full Text] [Related]
10. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis. Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155 [TBL] [Abstract][Full Text] [Related]
11. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors. Masuelli L; Focaccetti C; Cereda V; Lista F; Vitolo D; Trono P; Gallo P; Amici A; Monaci P; Mattei M; Modesti M; Forni G; Kraus MH; Muraro R; Modesti A; Bei R Int J Oncol; 2007 Feb; 30(2):381-92. PubMed ID: 17203220 [TBL] [Abstract][Full Text] [Related]
12. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; BisarĂ² B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor tyrosine kinase inhibitor does not improve paclitaxel effect in an orthotopic mouse model of lung cancer. Onn A; Isobe T; Wu W; Itasaka S; Shintani T; Shibuya K; Kenji Y; O'reilly MS; Fidler IJ; Herbst RS Clin Cancer Res; 2004 Dec; 10(24):8613-9. PubMed ID: 15623645 [TBL] [Abstract][Full Text] [Related]
14. Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenografts. Mellinghoff IK; Tran C; Sawyers CL Cancer Res; 2002 Sep; 62(18):5254-9. PubMed ID: 12234993 [TBL] [Abstract][Full Text] [Related]
15. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis. Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255 [TBL] [Abstract][Full Text] [Related]
16. Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function. Humphreys RC; Rosen JM Cell Growth Differ; 1997 Aug; 8(8):839-49. PubMed ID: 9269893 [TBL] [Abstract][Full Text] [Related]
17. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676 [TBL] [Abstract][Full Text] [Related]
18. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice. Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601 [TBL] [Abstract][Full Text] [Related]
19. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice. Kim SJ; Uehara H; Karashima T; Shepherd DL; Killion JJ; Fidler IJ Clin Cancer Res; 2003 Mar; 9(3):1200-10. PubMed ID: 12631626 [TBL] [Abstract][Full Text] [Related]
20. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Kang KS; Sun W; Nomata K; Morita I; Cruz A; Liu CJ; Trosko JE; Chang CC Mol Carcinog; 1998 Apr; 21(4):225-33. PubMed ID: 9585252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]